Grimée R - Search Results

1

Levetiracetam potentiates the antidyskinetic action of amantadine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.

Hill MP, Ravenscroft P, Bezard E, Crossman AR, Brotchie JM, Michel A, Grimée R, Klitgaard H. Hill MP, et al. Among authors: grimee r. J Pharmacol Exp Ther. 2004 Jul;310(1):386-94. doi: 10.1124/jpet.104.066191. Epub 2004 Mar 5. J Pharmacol Exp Ther. 2004. PMID: 15004218

2

Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L-dopa and ropinirole in the MPTP-lesioned marmoset.

Hill MP, Bezard E, McGuire SG, Crossman AR, Brotchie JM, Michel A, Grimée R, Klitgaard H. Hill MP, et al. Among authors: grimee r. Mov Disord. 2003 Nov;18(11):1301-5. doi: 10.1002/mds.10542. Mov Disord. 2003. PMID: 14639671

3

Levetiracetam improves choreic levodopa-induced dyskinesia in the MPTP-treated macaque.

Bezard E, Hill MP, Crossman AR, Brotchie JM, Michel A, Grimée R, Klitgaard H. Bezard E, et al. Among authors: grimee r. Eur J Pharmacol. 2004 Feb 6;485(1-3):159-64. doi: 10.1016/j.ejphar.2003.11.065. Eur J Pharmacol. 2004. PMID: 14757136

4

Levetiracetam Interferes With the L-dopa priming process in MPTP-lesioned drug-naive marmosets.

Hill MP, Brotchie JM, Crossman AR, Bezard E, Michel A, Grimée R, Klitgaard H. Hill MP, et al. Among authors: grimee r. Clin Neuropharmacol. 2004 Jul-Aug;27(4):171-7. doi: 10.1097/01.wnf.0000135478.70905.3d. Clin Neuropharmacol. 2004. PMID: 15319703

5

Electrophysiological, neurochemical and regional effects of levetiracetam in the rat pilocarpine model of temporal lobe epilepsy.

Klitgaard H, Matagne A, Grimee R, Vanneste-Goemaere J, Margineanu DG. Klitgaard H, et al. Among authors: grimee r. Seizure. 2003 Mar;12(2):92-100. doi: 10.1016/s1059131102001930. Seizure. 2003. PMID: 12566232 Free article.

6

Failure of GPI compounds to display neurotrophic activity in vitro and in vivo.

Bocquet A, Lorent G, Fuks B, Grimée R, Talaga P, Daliers J, Klitgaard H. Bocquet A, et al. Among authors: grimee r. Eur J Pharmacol. 2001 Mar;415(2-3):173-80. doi: 10.1016/s0014-2999(01)00850-0. Eur J Pharmacol. 2001. PMID: 11274996

7

In vitro properties of 5-(benzylsulfonyl)-4-bromo-2-methyl-3(2H)-pyridazinone: a novel permeability transition pore inhibitor.

Fuks B, Talaga P, Huart C, Hénichart JP, Bertrand K, Grimée R, Lorent G. Fuks B, et al. Among authors: grimee r. Eur J Pharmacol. 2005 Sep 5;519(1-2):24-30. doi: 10.1016/j.ejphar.2005.06.046. Eur J Pharmacol. 2005. PMID: 16099453

8

Dual NK(1) antagonists--serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives.

Ryckmans T, Berton O, Grimée R, Kogej T, Lamberty Y, Pasau P, Talaga P, Genicot C. Ryckmans T, et al. Among authors: grimee r. Bioorg Med Chem Lett. 2002 Nov 4;12(21):3195-8. doi: 10.1016/s0960-894x(02)00563-2. Bioorg Med Chem Lett. 2002. PMID: 12372532

9

Acute stress in rats produces a rapid and sustained increase in prostacyclin production in aortic tissue: dependence on corticosterone.

Grimée R, Wülfert E. Grimée R, et al. Life Sci. 1995;57(1):69-81. doi: 10.1016/0024-3205(95)00244-z. Life Sci. 1995. PMID: 7596223

10

Formation and degradation of 1-(ethyl)-1-(2-hydroxyethyl) aziridinium chloride in aqueous media--a comparative NMR study.

Goldstein S, Grimee R, Hanin I, Wulfert E. Goldstein S, et al. Among authors: grimee r. J Neurosci Methods. 1988 Mar;23(2):101-5. doi: 10.1016/0165-0270(88)90181-1. J Neurosci Methods. 1988. PMID: 3357352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters